Check in often for a current list of national research funding and award opportunities with upcoming deadlines.

Directory

Ongoing

A-T Children’s Project – Research Grant Program

• Due: LOI submission rolling
• Funding: Up to $75,000 per year
• Project period: 1 to 2 years
• Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
• Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.

Alexander von Humboldt Research Foundation – Humboldt Research Fellowship

• Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
• Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
• Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
• Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
• Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.

Allen Institute for AI – Allen AI Young Investigators

• Due: Rolling
• Funding: $100,000
• Project period:  1 to 3 years
• Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
• Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)

• Due: Rolling
• Funding: $100,000 to $1M
• Project period:  1 to 2 years
• Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
• Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

• Due: Open
• Funding:Up to $1M
• Project period:  Up to 3 years
• Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
• Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals

• Due: Annually October 15 and April 15
• Funding: Up to $100,000 per year
• Project period:  1 to 2 years
• Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
• Eligibility: Researchers at all levels are eligible.

Boehringer Ingelheim U.S. – Investigator-Initiated Studies (IIS)

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
• Eligibility: Intended for U.S. based researchers.

Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award

• Due: LOI submission rolling
• Funding: Negotiable
• Project period:  Not specified
• Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
• Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.

Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants

• Due: January 1 (Round 1); July 1 (Round 2) annually
• Funding: $25,000-$50,000
• Project period: 1 to 2 years
• Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
• Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas. 

Cystic Fibrosis Foundation – Student Loan Repayment Program

• Due: During and up to 4 months after active award period
• Funding: $14,000 per year maximum
• Project period: One-time payment
• Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
• Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.

Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience

• Due: Rolling
• Funding: Stipend (amount not specified)
• Project period: 1 year
• Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
• Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.

Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $250,000
• Project period: 2 years
• Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
• Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.

Foundation for Anesthesia Education and Research (FAER) – Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $75,000
• Project period: 1 year
• Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
• Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.

Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant

• Due: Rolling
• Funding: $75,000
• Project period: 1 year
• Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.

Gateway for Cancer Research – GFCR Grant Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – SIO Integrative Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – NCI/SPORE Program

• Due: Rolling
• Funding: $200,000 to $800,000
• Project period: 2 to 5 years
• Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis. 
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Immune Tolerance Network – Request for Applications

• Due: Open; Concept Proposals accepted year-round
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
• Note: ITN does not accept proposals for non-human or preclinical studies.

NIH – Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)

MOSAIC K99/R00 – Independent Clinical Trial Not Allowed
MOSAIC K99/R00 – Independent Clinical Trial Required
MOSAIC K99/R00 – Independent Basic Experimental Studies with Humans Required (BESH)

• Due: Rolling
• Funding: Varies
• Project period: Up to 5 years (2 years K99; 3 years R00)
• Purpose: To support early career, independent investigators from diverse backgrounds conducting research related to NIH mission.
• Eligibility: Candidates from underrepresented racial and ethnic groups as well as individuals with disabilities, women and individuals from disadvantaged backgrounds are encouraged to apply. Open to early career candidates working with a mentor.

NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

• Due: Standard March dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.

NIH/NCI– Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

• Due: Standard due dates; May 5, 2024, September 5, 2024 (2024 LOI dates)
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support innovative research related to advancing understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent/mitigate negative health effects, including, but not limited to, studies to improve knowledge of the impact of climate change related environmental effects on cancer risks, control, and behaviors.
• Eligibility: Open to researchers at any level.

NIH/NCI – Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)

• Due: Standard due dates; May 16, 2024, September 16, 2024 (2024 LOI dates)
• Funding: Up to $275,000
• Project period: 2 years
• Purpose: To support exploratory and novel research using the R21 grant mechanism relevant to advancing understanding of the effects of climate change on cancer risks, control, and survivorship, and ways to prevent or mitigate negative health effects.
• Eligibility: Open to researchers at any level.

NIH/NHLBI – Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE)

• Due: Pre-applications considered on a rolling basis
  • Full applications accepted by invitation
• Funding: All-expense-paid Summer Institute Program via NHLBI
• Project period: One summer
• Purpose: To provide mentoring to junior investigators and tr
• ansitioning postdoctoral fellows from underrepresented backgrounds. Distinct programs offered across multiple campuses.
• Eligibility: 1) U.S. citizen or permanent resident; 2) holds doctoral degree (e.g., PhD, MD, DO, DVM); 3) from a group that is underrepresented in biomedical or health sciences; 4) research focus on heart, lung, blood or sleep (HLBS) disorders; and 5) hold formal faculty appointment before start of Summer Institute Program.

NIH/NHLBI – Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research

K01 Independent Clinical Trial Required
K01 Independent Clinical Trial Not Allowed

• Due: Standard October and February dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To promote diversity in the biomedical, behavioral, clinical and social sciences workforce.

NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
• Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.

NIH – Research Supplements to Promote Diversity in Health-Related Research

• Due: Varies by awarding IC
• Funding: Not specified
• Project period: Within project period of active grant
• Purpose: To enhance the diversity of the research workforce by recruiting and supporting students, postdocs, and eligible investigators from diverse backgrounds.
• Note: As of January 2021, NIGMS accepts applications to support faculty-level investigators developing independent research careers. Faculty who haven’t previously served as program director or principal investigator on NIH research grant, individual research career development award, or project leader of a NIH award subproject.

NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.

NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population

• Due: Rolling through May 7, 2029
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
• Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.

NIH –Notice of Special Interest: Secondary Analysis of Posttraumatic Psychopathology Data

• Due: Rolling through January 8, 2025
• Funding: Varies
• Project Period: Varies
• Purpose: To support research that analyzes existing and accumulating data to help in refining phenotypes of posttraumatic psychopathology(ies), markers of onset and change, and risk, detection and to identify potential prevention and treatment targets.
• Eligibility: Early career and established investigators encouraged to apply.

NIH – Notice of Special Interest: Secondary Analysis of Posttraumatic Psychopathology Data

• Due: Rolling through January 8, 2025
• Funding: Varies
• Project period: Varies
• Purpose: To support research that analyzes existing and accumulating data to help in refining phenotypes of posttraumatic psychopathology(ies), markers of onset and change, and risk, detection and to identify potential prevention and treatment targets.
• Eligibility: Early career and established investigators encouraged to apply.

NIH/NIMH – NIMH Instrumentation Program (S10 Clinical Trial Not Allowed)

• Due dates: October 9, 2024

National Institutes of Health – Career Development (K) Awards

• New Applications due: annually on June 12, October 12
• Renewal/Revision/Resubmission: annually on March 12, July 12, November 12

National Institutes of Health – Individual Fellowship (F) Awards

National Institutes of Health – NIH Small Grant Program (R03)

Robert Wood Johnson Foundation – Evidence for Action: Innovative Research to Advance Racial Equity

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that focuses on improving health, well-being and health outcomes for marginalized groups of people.
• Eligibility: Organizations based in the US and its territories are eligible to apply. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants

• Due: Rolling
• Funding: Up to $4,000
• Project Period: 6 months.
• Purpose: To fund statistical and/or publication support of active PeDRA Studies
• Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.

Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
• Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

Simons Foundation – SFARI Supplement to Enhance Equity and Diversity (SEED) RFA

• Due: Rolling
• Funding: $100,000 per year
• Project period: Up to 3 years
• Purpose: Provides supplements to existing grants so PIs can recruit new lab members from American underrepresented minority groups at the postdoctoral level (must be U.S. citizens).
• Eligibility: SFARI PIs may apply if there are at least 18 months remaining on their SFARI-funded project. Postdoctoral applicants from American underrepresented minority groups who are U.S. citizens eligible to apply. Funding restricted to institutions in the U.S.

Tourette Association of America – Support for Research Consortia and Collaborative Research Projects

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
• Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.

f

April

Patient-Reported Outcomes Tools: Engaging Users & Stakeholders (PROTEUS) Consortium & Pfizer Global Medical Grants – Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care

• Due: April 25, 2024 (LOI)
• Funding: Up to $100,000
• Project Period: 1 year
• Purpose: To support research on the value of using patient-reported outcome measures (PROMP in oncology clinical practice for individual patient care.
• Eligibility: Open to U.S.-based applicants and projects. Only organizations are eligible to receive grants. PIs must have an MD, PhD or equivalent. Multidisciplinary teams are encouraged, with clinical and methodologic expertise and patient partners.

Pfizer-Crohn’s & Colitis Foundation – Pfizer Global Medical Grants RFP: IBD QORUS Health Equity Requests for Applications

• Due: April 25, 2024
• Funding: Up to $125,000
• Project Period: 2 years
• Purpose: A collaborative effort by Pfizer and Crohn’s & Colitis Foundation to build a small cohort of IBD centers, consisting of new and/or existing Qorus sites, to collaborate on resources, platforms and practices that improve success in the delivery of quality care to racially and ethnically diverse populations.
• Eligibility: US-based healthcare institutions that care for IBD patients and are physically located in a disadvantaged community and/or provide care to primarily underserved or minority populations are eligible.

The Mark Foundation for Cancer Research – Emerging Leader Award

• Due: April 29, 2024 (LOI)
• Funding: $750,000
• Project Period: 3 years
• Purpose: To support outstanding early career investigators conducting innovative, high-impact, high-risk projects in cancer research that are distinct from their current research portfolio.
• Eligibility: PIs must hold an MD, PhD, or equivalent and be employed by a U.S. or Canadian non-profit academic institution and be three to eight years from the start of an independent faculty research appointment as of December 31, 2024. Additional funding might be available based on project progress.

Elsa U. Pardee Foundation –  Cancer Research Grants Program

• Due: April 30, 2024
• Funding: Not specified
• Project Period: 1 year
• Purpose: To support new scientists with the most innovative and cutting-edge grant proposals identifying new treatments or cures for fighting cancer.
• Eligibility: Intended for new cancer research scientists or new approaches by established scientists in the U.S. who are affiliated with non-profit organizations.

Foundation for Anesthesia Education and Research & National Academy of Medicine – FAER-NAM Fellowship

• Due: April 30, 2024
• Funding: Up to $25,000
• Project Period: 2 years
• Purpose: To provide early career full-time anesthesiology faculty with the opportunity to gain experience and participate in evidence-based health care or public health studies that improve care and access for patients in domestic and global health care systems.
• Eligibility: Applicants must be MD, DO, or equivalent full-time anesthesiology faculty (2-10 yrs beyond completion of post-graduate work) who are U.S citizens or permanent residents. 10-20% protected time and membership required.

ThermoFisher – Oncomine Clinical Research Grant Program

• Due: April 30, 2024
• Funding: Up to $200,000
• Project Period: Up to 1 year
• Purpose: To support investigator-initiated and education projects on molecular testing in oncology and reproductive health to increase quality molecular profiling to improve clinical outcomes for cancer patients.
• Eligibility: Independent researchers with research projects related to unmet diagnostics needs using next-generation sequencing for both solid and hematological cancers and those aiming to demonstrate the value of fast complete molecular diagnostics encouraged to apply.

May

Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation) – Faculty Starter Grants

• Due: May 1, 2024 (LOI)
• Funding: $100,000
• Project Period: 1 year
• Purpose: To support faculty who have not yet received substantial research funding.
• Eligibility: Applicants must be full-time, promotion-eligible, research-intensive faculty with PhD and/or MS degree-granting U.S. university and be eligible to apply for independent external research funding by their university. Candidates not eligible if faculty appointment began prior to January 1, 2022.
• Note: Award Mechanisms: Drug Discovery; Drug Delivery; Translational Medicine

Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation) – Postdoctoral Fellowship

• Due: May 1, 2024 (LOI)
• Funding: $60,000 per year
• Project Period: 12, 18, or 24 months
• Purpose: To provide a stipend to support promising postdoctoral trainees seeking to gain experience and development as a researcher.
• Eligibility: Applicants must be current PhDs, PharmDs, MDs, or equivalent in a field related to the award mechanism for which they seek funding or anticipate receiving the doctoral degree before start of the award. Candidates not eligible if doctoral degree was granted before January 1, 2022.
• Note: Award Mechanisms: Drug Discovery; Drug Delivery; Translational Medicine

William T. Grant Foundation – Research Grants on Improving the Use of Research Evidence

• Due: May 1, 2024
• Funding: $100,000 to $1,000,000
• Project Period: 2 to 4 years
• Purpose: Supports projects that seek to advance theory and build empirical knowledge regarding ways to improve the use of research evidence by policymakers, agency leaders, organizational managers, intermediaries, and other decision-makers shaping youth-serving systems in the U.S. Officers’ Research Grants are also offered: $25,000-$50,000 over 1-2 years.
• Eligibility: Awards limited to tax-exempt organizations. Proof of exempt status is required. PI and Co-PI selection subject to applying institution’s eligibility criteria. Interdisciplinary projects encouraged. Projects led by persons from racial or ethnic groups underrepresented in academic fields, teams with mentoring partnerships encouraged.

William T. Grant Foundation – Research Grants on Reducing Inequality

• Due: May 1, 2024
• Funding: $100,000 to $600,000
• Project Period: 2 to 3 years
• Purpose: To support studies that aim to reduce inequalities that exist along dimensions of race, ethnicity, economic standing, language minority status, or immigrant origins in areas of academics, social, behavioral, or economic outcomes of young people ages 5-25 living in the U.S. Officers’ research grants are also available: $25,000-$50,000 over 1-2 years.
• Eligibility: Grants limited to tax-exempt organizations. Selection of PIs and Co-PIs subject to their institution’s eligibility criteria. Interdisciplinary projects encouraged.

Global Bridges at Mayo Clinic & Pfizer Global Medical Grants – Quality Improvement RFP: Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis

• Due: May 2, 2024
• Funding: Up to $225,000
• Project Period: 2 years
• Purpose: To support independent projects aimed at raising awareness and closing knowledge gaps to reduce the time it takes for correctly diagnosing patients and making treatment more accessible, while supporting the development of a global network of TTR amyloidosis experts to help decrease the distance patients need to travel for diagnosis.
• Eligibility: This grant will be awarded to institutions only.Professional schools, hospitals, healthcare systems, universities, patient advocacy groups, professional associations, government agencies welcome to apply.

NIH – HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

• Due: May 04, 2024 (LOI)
• Funding: Not specified
• Project Period: Up to 5 years
• Purpose: To support basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. Research must include rigorous validation studies to demonstrate the robustness of the target as a pain treatment target.
• Eligibility: Researchers at any level with the skills and knowledge to conduct the proposed research are eligible.

NIH/NCI – Impacts of Climate Change Across the Cancer Control Continuum (R01 Clinical Trial Optional)

• Due: May 5, 2024
• Funding: Up to $275,000
• Project Period: Up to 2 years
• Purpose: To support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects.
• Eligibility: For researchers with the skills, knowledge, and resources necessary to conduct the proposed project.

Bristol Myers Squibb Foundation – Robert A. Winn Diversity in Clinical Trials Awards Program Career Development Award (Winn CDA) for Early-Stage Investigator Physicians

• Due: May 13, 2024
• Funding: $120,000 per year
• Project Period: 2 years
• Purpose: To support career development of early-stage physician scientists who are underrepresented in medicine or physicians who demonstrate commitment to increasing diversity in clinical research, and to becoming independent clinical trial investigators engaged in advancing health equity through research and mentoring.
• Eligibility: Candidates must hold an MD, MD/PhD, DO or DO/PhD and have earned a terminal degree or residency within the past 10 years, identify as a member of a racial/ethnic group underrepresented in medicine, or have a demonstrated commitment to increasing diverse patient participation in clinical trials. 40% protected time required. For early stage investigators who have not been awarded and R01 or equivalent. U.S. citizenship, permanent residency or H-1B or O-1 Visa required. Mentor required.

Howard Hughes Medical Institute – HHMI Freeman Hrabowski Scholars Program

• Due: May 15, 2024
• Funding: $400,000 per year
• Project Period: 5 years
• Purpose: To help scientists build their careers by helping them maintain an academic appointment and lab at their own research institutions (this is a five-year appointment with the opportunity for a five-year renewal based on progress). Designed for scholars to engage in research (80% protected time), professional activities like teaching, academic service, patient care, and consulting (per HHMI consulting policies).
• Eligibility: Candidates must have a PhD, MD, or equivalent. They must have began their first post-training position and a tenure-track (or equivalent) faculty position on or after March 1, 2020, or have accepted an offer for tenure-track position (or equivalent) that starts no later than March 1, 2025.

NIH/NCI – Impacts of Climate Change Across the Cancer Control Continuum (R21 Clinical Trial Optional)

• Due: May 16, 2024
• Funding: Not specified
• Project Period: Up to 5 years
• Purpose: To support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects.
• Eligibility: For researchers with the skills, knowledge, and resources necessary to conduct the proposed project.

June

Alzheimer’s Drug Discovery Foundation/Harrington Discovery Institute – Center for Dementia Respite Innovation (CDRI)

• Due: June 1, 2024
• Funding: $50,000 to $250,000
• Project Period: 1 year (w/ additional year possible)
• Purpose: To enhance respite services for people living with dementia and their caregivers nationwide. CDRI will support grant recipients through online training and technical assistance.
• Eligibility:
• To enhance respite services for people living with dementia and their caregivers nationwide. CDRI will support grant recipients through online training and technical assistance.
• Eligibility: Domestic public or private, licensed or certified, non-profit entities with demonstrated capacity to provide culturally competent dementia-specific respite services.

Alzheimer’s Drug Discovery Foundation/Harrington Discovery Institute – ADDF-Harrington Scholar Program

• Due: June 3, 2024 (LOI)
• Funding: Up to $600,000
• Project Period: Over 2 years
• Purpose: To provide funding and project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute Center for Brain Health Medicines. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones.
• Eligibility: Academic investigators at accredited medical centers, research institutions, and universities in the United States, Canada and United Kingdom only are eligible to apply. Lead PI must be an MD, PhD or equivalent. The team should possess intellectual property (IP) or have potential for novel IP that has not yet been licensed to a for-profit entity.

Alex’s Lemonade Stand Foundation for Childhood Cancer – 2024 R Accelerated Award Grant

• Due: June 6, 2024
• Funding: $800,000
• Project Period: Over 4 years
• Purpose: To support original projects not currently funded, clearly focused on accelerating discovery of less toxic, more effective therapies for pediatric cancers.
• Eligibility: Applicant’s institution must be U.S.- or Canada-based. Applicants must have MD, PhD, MD/PhD (DO, MBBS or equivalent) and be within 10 years of their first faculty appointment at the Assistant Professor level (higher academic ranks allowed). Applicants must be first-time recipients of a pediatric cancer research-focused NIH R01 award or equivalent.

NIH – NIH Science Education Partnership Award (SEPA) (R25 Clinical Trial Not Allowed)

• Due: June 7, 2024
• Funding: Up to$250,000
• Project Period: Up to 5 years
• Purpose: To support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. Activities should focus on courses for skills development, research experiences, mentoring activities, curriculum or methods development, and/or outreach.
• Eligibility:
• Open to researchers at any level. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are encouraged to apply.

Alex’s Lemonade Stand Foundation for Childhood Cancer – ‘A’ Award Grant Program

• Due: June 13, 2024
• Funding: $800,000
• Project Period: Over 4 years
• Purpose: To provide support for an unfunded original project that will be conducted by and early career scientists seeking to establish a career in pediatric oncology research.
• Eligibility: Applicants must have an MD, PhD, or MD/PhD and be within 10 years of their terminal degree and 5 years of their first faculty appointment as an Assistant Professor at the time the grant application is submitted. Applicant institutions must be based in the United States or Canada.

Russell Sage Foundation – Visiting Scholar

• Due: June 25, 2024
• Funding: Up to $125,000; up to $62,500
• Project Period: 1 year; 6 months
• Purpose: To provide a unique opportunity for early career scholars in the social, economic, political and behavioral sciences to pursue data analysis and writing while in residence at the foundation’s headquarters located in New York City. Projects will be focused on the foundation’s core programs: Behavioral Science and Decision Making in Context; Future of Work; Race, Ethnicity and Immigration; Social, Political and Economic Inequality) and special initiatives.
• Eligibility: For postdoctoral scholars who are at least two years past their terminal degree or individuals with a career background that demonstrates their ability to conduct high-quality, peer-reviewed scholarly research.

July

Damon Runyon Cancer Research Foundation – Damon Runyon-Rachleff Innovation Award Stage 1

• Due: July 8, 2024
• Funding: $200,000 per year
• Project Period: 2 years (4-year maximum if approved)
• Purpose: To fund high-risk/high-reward research to allow researchers to gather preliminary data necessary for securing larger grants.
• Eligibility: Applicants must have an MD, DO, or PhD from an accredited institution and be conducting independent research at a U.S.-based institution. Basic and translational/clinical projects will be considered.

Damon Runyon Cancer Research Foundation – Damon Runyon-Dale F. Frey Award for Breakthrough Scientists

• Due: July 15, 2024
• Funding: $100,000
• Project Period: Up to 2 years
• Purpose: To support the nation’s top postdoctoral fellow by enabling them to complete training under mentorship of a leading senior scientist and to encourage the pursuit of bold ideas.
• Eligibility: Damon Runyon Fellows in the fourth year of their fellowship, current fellows selected in November 2020, May 2021, and February 2022. Fellows who have terminated their awards early to accept an independent academic faculty position or other funding are eligible to apply.

September

NIH/NINDS – Neuroscience Development for Advancing the Careers a Diverse Research Workforce (R25 Clinical Trial Not Allowed)

• Due: August 26, 2024 (LOI)
• Funding: $200,000 maximum
• Project Period: Up to 5 years
• Purpose: To support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue advanced studies or careers in research.
• Eligibility: PD/PI candidates should hold a basic or health professional degree (e.g. PhD, MD, or equivalent), and have a track record of training/mentoring credentials. The PD/PI must have a regular, full-time appointment at their institution and should have research, teaching, and/or academic administrative experience. Early-stage investigators are eligible to serve as PD/PIs, if the project does not detract from their research program and career advancement.

NIH – National Institute of Mental Health (NIMH) Instrumentation Program (S10 Clinical Trial Not Allowed)

• Due: September 10, 2024 (LOI)
• Funding: $200,000 to$600,000 
• Project Period: 1 year
• Purpose: To encourage applications from NIH funded investigators to purchase or upgrade a single commercially available instrument or to purchase a group of components to create an instrument that is not commercially available.
• Eligibility: PIs at any level who have the support of their institution, the knowledge, skills and resources necessary.

NIH – Notice of Intent to Publish a Notice of Funding Opportunity for National Cancer Institute’s Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54 Clinical Trial Optional)

• Due: September 25, 2024
• Funding: $1.6M per year maximum
• Project Period: Not specified
• Purpose: To support a network of multidisciplinary, multi-institutional U54 CHD-MH SPOREs, which are multi-project awards uniquely focused on health disparities and/or minority health translational research for improved prevention, early detection, diagnosis, and treatment of cancer in populations who are underserved. (More than one cancer can be investigated, including groups of highly related cancers (e.g., gastrointestinal or head and neck).
• Eligibility: The U54 CHD-MH SPOREs require various components to include: a minimum of three translational research projects, each with a human endpoint, must be proposed, and a research base of four or more independent investigators who currently serve as PDs/PIs (or project leaders) on peer-reviewed research grants or are overall/site chairpersons on an active NCI-sponsored clinical trial. See other requirements.

Awards

May

NOMIS & Science – Young Explorer Award

• Deadline: May 15, 2024
• Prize: $25,000
• Purpose:
• Grand prize: $15,000; Runner(s) Up: $5,000 (plus 5-year digital subscription to Science and publication of essay)
• Purpose: Granted annually to recognize 1 bold young researcher who has performed interdisciplinary work involving cross-field collaboration; for high-risk research. The Grand Prize Award winner is automatically eligible to submit a funding proposal to the NOMIS board.
• Eligibility: Applicants must be thirty-five years of age or younger and hold an MD, PhD or MD/PhD received within the last 10 years at the time of entry. For early career scientists based on work done in the past 3 years.

June

Eppendorf & Science – Eppendorf & Science Prize for Neurobiology

• Deadline: June 15, 2024
• Prize: $25,000
• Purpose: To encourage and support research by promising young neurobiologists.
• Eligibility: Applicants must be early career scientists, no older than thirty-five (35) years of age and hold an MD, PhD or MD/PhD received within the last 10 years, at the time of entry. For early career scientists based on work done in the past 3 years. Entry essay focus: contributions to neurobiological research based on methods of molecular, cellular, systems, or organismic biology (this work must have been performed within the last 3 years).

American Association for the Advancement of Science (AAAS) – AAAS Mentor Awards

• Deadline: June 30, 2024
• Prize: $5,000 (Lifetime Mentor Award); $5,000 (Mentor Award)
• Purpose: Honors individuals who have mentored and guided significant numbers of students from underrepresented groups to the completion of doctoral studies or who has impacted the climate of a department, college, or institution to significantly increase the diversity of students pursuing and completing doctoral studies.
• Eligibility: Mentor Award: Candidates must have served in a mentor role for less than 25 years. Lifetime Mentor Award: Candidates must have served in the role of mentor for 25 year or more. Open to all individuals who have mentored a significant number of students from underrepresented groups who earned PhDs in a STEM field. View award details for all eligibility requirements.

American Association for the Advancement of Science (AAAS) – AAAS Early Career Award for Public Engagement with Science

• Deadline: June 30, 2024
• Prize: $5,000
• Purpose: To recognize early career scientists & engineers who demonstrate excellence in their contribution to public engagement w/ science activities. Public engagement activities must be above and beyond job responsibilities. The winner will be announced at the annual conference.
• Eligibility: Applicants must be early career scientists w/ terminal degree obtained within the past 7 years. Self nominations accepted.

American Association for the Advancement of Science (AAAS) – AAAS Mani L. Bhaumik Award for Public Engagement with Science

• Deadline: June 30, 2024
• Prize: $5,000
• Purpose: To recognize scientists, mathematicians, and engineers who demonstrate excellence not only in their research careers but also in contributing substantially to the public’s engagement with science or technology. Public engagement activities must be above and beyond job responsibilities.
• Eligibility: Nominees must represent a field of science (including social science), technology, engineering, math (STEM), and Medicine, and be based in academia, government, or industry. Self-nominations allowed.

American Association for the Advancement of Science (AAAS) – John P. McGovern Award Lecture in the Behavioral Sciences

• Deadline: June 30, 2024
• Prize: $5,000
• Purpose: To enable scholars to learn and explore the accomplishments and challenges of the behavioral sciences.  Winner will have the opportunity to deliver the John P. McGovern Award Lecture in the Behavioral Sciences at the 2025 Annual Meeting (Boston, MA).
• Eligibility: Candidates must be researchers or academics and should be engaging and dynamic speakers in the behavioral sciences field. Contributions can include research, publications, professorship, mentorship, etc. and must be considered substantial to the field.

AAAS & Science – AAAS Newcomb Cleveland Prize

• Deadline: June 30, 2024
• Prize: $25,000
• Purpose: To recognize the author or authors of an outstanding paper published in the Research Articles or Reports sections of Science. Eligible papers may include original research data or theory, and broaden or improve basic knowledge or embody a technical achievement with a wide impact.
• Eligibility: The paper must be a first-time publication of the author’s original research work.

About the Author

Screen Name

The Edge for Scholars

About Me

We post stuff you shouldn't miss.